High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation
IntroductionAHSCT is the treatment of choice for newly diagnosed patients with transplant-eligible multiple myeloma (MM). However, considerable variability in response to autologous hematopoietic stem cell transplantation (AHSCT) results in only 50% of patients achieving complete response (CR) after...
Main Authors: | Damian Mikulski, Mateusz Nowicki, Izabela Dróźdż, Małgorzata Misiewicz, Kacper Piotr Kościelny, Karol Okoński, Kinga Krawiec, Ewelina Perdas, Agnieszka Wierzbowska, Wojciech Fendler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1250355/full |
Similar Items
-
Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection
by: Kirstine K. Rasmussen, et al.
Published: (2023-08-01) -
Differential Expression of miRNA-223 in Coronary In-Stent Restenosis
by: Shiva Ganjali, et al.
Published: (2022-02-01) -
The Multiple Roles of Microrna-223 in Regulating Bone Metabolism
by: Yong Xie, et al.
Published: (2015-10-01) -
P551: EVALUATION OF PROGNOSTIC FACTORS FOR SURVIVAL AND TREATMENT OUTCOMES OF PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIA – A SINGLE-CENTER STUDY
by: Piotr Strzałka, et al.
Published: (2023-08-01) -
Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation
by: Nomura S, et al.
Published: (2016-01-01)